Certified by Founder
Lodge
Caristo Diagnostics
start up
United Kingdom
- Oxford
- 18/04/2023
- Series A
- $16,300,000
Caristo Diagnostics has been formed to bring revolutionary cardiovascular diagnostic tools to patients worldwide. Our proprietary technology transforms the accuracy of routine cardiac CT scans by extracting new information that is otherwise invisible, greatly enhancing the power to predict cardiovascular risk and refine treatment decisions.
Our Website: https://www.caristo.com
Follow us on Twitter: https://twitter.com/CaristoHeart
- Industry Medical Equipment Manufacturing
- Website https://www.caristo.com/
- LinkedIn https://www.linkedin.com/company/caristo/people/
Related People
Frank ChengFounder
United States -
ND
Currently leading healthcare AI business. Previously led innovative businesses in robotic surgery, digital diagnostics, HCIT, and diagnostic imaging.
Atlas Invest | $25,000,000 | (Jan 22, 2026)
AiStrike | $7,000,000 | (Jan 22, 2026)
Zarminali Pediatrics | $110,000,000 | (Jan 22, 2026)
AnswersNow | $40,000,000 | (Jan 22, 2026)
Upscale AI(US) | $200,000,000 | (Jan 22, 2026)
Nasdaq Private Market | $37,600,000 | (Jan 22, 2026)
PraxisPro | $6,000,000 | (Jan 22, 2026)
furl | $10,000,000 | (Jan 22, 2026)
Statusphere | $18,000,000 | (Jan 21, 2026)
Think Bioscience | $55,000,000 | (Jan 21, 2026)
ErVimmune | $19,917,795 | (Jan 21, 2026)
Formulary Financial | $4,600,000 | (Jan 21, 2026)